Document is current
Any future updates will be listed below
-
Authors
Zhang, Bingnan
Ramkumar, Kavya
Cardnell, Robert John
Gay, Carl Michael
Stewart, C. Allison
Wang, Wei-Lien
Fujimoto, Junya
Wistuba, Ignacio I.
Byers, Lauren Averett http://orcid.org/0000-0002-0780-2677
- License Information
-
More Information
Article History
Received: 2 February 2021
Revised: 25 May 2021
Accepted: 17 June 2021
First Online: 22 July 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Dr. Byers serves on advisory committees for AstraZeneca, AbbVie, GenMab, BergenBio, Pharma Mar SA, Sierra Oncology, Merck, Bristol-Myers Squibb, Genentech, and Pfizer and has research support from AbbVie, AstraZeneca, GenMab, Sierra Oncology, Tolero Pharmaceuticals. Dr. Wistuba reports grants and personal fees from Genentech/Roche, grants and personal fees from Bayer, grants and personal fees from Bristol-Myers Squibb, grants and personal fees from AstraZeneca/Medimmune, grants and personal fees from Pfizer, grants and personal fees from HTG Molecular, grants and personal fees from Merck, personal fees from GlaxoSmithKline, grants and personal fees from Guardant Health, personal fees from MSD, grants from Oncoplex, grants from DepArray, grants from Adaptive, grants from Adaptimmune, grants from EMD Serono, grants from Takeda, grants from Amgen, grants from Karus, grants from Johnson & Johnson, grants from Iovance, grants from 4D, grants from Novartis, grants from Oncocyte, grants from Akoya, personal fees from Flame, outside the submitted work.
